Correction and Comment: Possible Toxicity from Propylene Glycol in Injectable Drug Preparations

Annals of Pharmacotherapy

Volumn 31, Issue 11, 1997, Pages 1413-

  Woycik, Cynthia L ^a   Walker, Paul C ^b  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b DETROIT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; DIAZEPAM; LACTIC ACID; LORAZEPAM; MANNITOL; MIDAZOLAM; PENTOBARBITAL; PROPYLENE GLYCOL; DRUG VEHICLE;

ADOLESCENT; ANION GAP; CASE REPORT; CONTINUOUS INFUSION; DRUG FORMULATION; ERRATUM; HUMAN; INJECTION; LACTIC ACIDOSIS; PRIORITY JOURNAL; SERUM OSMOLALITY; CHEMISTRY; CHILD; NOTE; VEHICLES;

CHEMISTRY, PHARMACEUTICAL; CHILD; HUMANS; LORAZEPAM; PENTOBARBITAL; PROPYLENE GLYCOL; VEHICLES;

EID: 0031262964     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809703101127     Document Type: Letter

References (3)

1. Package insert. Ativan injection (lorazepam). Philadelphia: Wyeth-Ayerst Laboratories, February 1995.
2. Package insert. Diazepam injection. Cherry Hill, NJ: Elkins-Sinn, October 1994.
3. D'Ambrosio JA, Borchardt-Phelps P, Nolen JG. Cerra FB. Propylene glycol-induced lacticacidosis secondary to a continuous infusion of lorazeparn (abstract). Pharmacotherapy 1993; 13:274.